mechlorethamine has been researched along with Hematologic Neoplasms in 4 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, M | 1 |
| Guo, W | 1 |
| Zhang, Z | 1 |
| Zhou, Y | 1 |
| Chen, J | 1 |
| Wang, T | 1 |
| Zhong, X | 1 |
| Lu, Y | 1 |
| Yang, Q | 1 |
| Wei, Q | 1 |
| Han, M | 1 |
| Xu, D | 1 |
| Gao, J | 1 |
| HORLIN, W | 1 |
| SCHMITT, W | 1 |
| Ogawa, M | 1 |
| Gandhi, MK | 1 |
| Jestice, K | 1 |
| Scott, MA | 1 |
| Bloxham, D | 1 |
| Bass, G | 1 |
| Marcus, RE | 1 |
1 review available for mechlorethamine and Hematologic Neoplasms
| Article | Year |
|---|---|
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
3 other studies available for mechlorethamine and Hematologic Neoplasms
| Article | Year |
|---|---|
Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Survival; Disease Models, Animal; Drug Compounding; | 2020 |
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen | 1957 |
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; | 1999 |